Results 111 to 120 of about 19,438 (169)

Genetic modifiers of APOE-ε4-associated cognitive decline. [PDF]

Nat Commun
Contreras AG, Walters S, Eissman JM, Archer DB, Regelson AN, Durant A, Clifton M, Mukherjee S, Lee ML, Choi SE, Scollard P, Trittschuh EH, Mez J, Bush WS, Kunkle BW, Cruchaga C, Naj AC, Gifford KA, Bilgel M, Kuzma AB, Alzheimer’s Disease Neuroimaging Initiative (ADNI), Alzheimer’s Disease Genetics Consortium (ADGC), Alzheimer’s Disease Sequencing Project (ADSP), Cuccaro ML, Pericak-Vance MA, Farrer LA, Wang LS, Schellenberg GD, Haines JL, Jefferson AL, Kukull WA, Keene CD, Saykin AJ, Thompson PM, Martin ER, Albert MS, Johnson SC, Engelman CD, Ferrucci L, Bennett DA, Barnes LL, Schneider JA, Sperling RA, Resnick SM, Crane PK, Dumitrescu L, Hohman TJ.   +46 more
europepmc   +1 more source

The Alzheimer\u27s Disease Sequencing Project: Study design and sample selection [PDF]

, 2017
et al,, Koboldt, D. C, Larson, D. E
core   +1 more source

Integrated genomic analysis and CRISPRi implicates <i>EGFR</i> in Alzheimer's disease risk. [PDF]

NPJ Dement
Leung YY, Kuksa PP, Carter L, Cifello J, Greenfest-Allen E, Valladares O, Boateng L, Laub S, Tulina N, Moura S, Ramirez A, Celis K, Jin F, Feng R, Wang G, De Jager P, Vance JM, Wang L, Grant SFA, Schellenberg GD, Chesi A, Wang LS.   +21 more
europepmc   +1 more source